HANNA PERCY: Open Payments
NPI 1225687759 · POCATELLO, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,203 in 63 payments from 14 companies in 2025. Trend: 2023 $878 · 2024 $2,103 · 2025 $1,203
Food & beverage: $1,203
| Company | Payments | Amount |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $216 |
| ABBVIE INC. | 13 | $213 |
| PFIZER INC. | 10 | $155 |
| Janssen Biotech, Inc. | 3 | $116 |
| Regeneron Healthcare Solutions, Inc. | 4 | $101 |
| Phathom Pharmaceuticals, Inc. | 5 | $75 |
| Aimmune Therapeutics, Inc. | 4 | $67 |
| GENZYME CORPORATION | 3 | $52 |
| Ardelyx, Inc. | 2 | $48 |
| QOL Medical, LLC | 2 | $42 |
Products named: ENTYVIO, DUPIXENT, TREMFYA, VELSIPITY, CREON, VOQUEZNA, LINZESS, RINVOQ.
Industry payments across ID — which companies pay providers there.
